Background: Increasing evidence of progressive damage to germ cell development in boys with cryptorchidism suggests recommending surgery until one year of age. However, despite early and successful orchidopexy, cryptorchid boys with impaired mini-puberty will suffer from infertility. We reviewed changes in the timing of surgery during the past decade and the incidence of unilateral cryptorchid boys with defective mini-puberty. Methods: Medical registries were reviewed for all patients who were operated on for cryptorchidism at the main pediatric urological center of the country. The ages of surgery in cases of unilateral cryptorchidism were compared between the years 2000-2001 and 2012-2013. A high risk of infertility was considered when no Ad spermatogonia were found. Two groups were compared: group I - operated on until the age of 1.5 years and group II - older than 1.5 years. Results: The average age at operation decreased from 5.3 to 4.1 years. Forty-six biopsies in boys with unilateral cryptorchidism were made during orchidopexy on undescended testicles. Overall, 44% in group I and 50 % in group II (p > 0.05) had no Ad spermatogonia. Conclusions: The average age of operation for cryptorchidism has decreased, but remains far above the recommended age. The high prevalence of histologically proven risk of infertility underscores the necessity of more education regarding the importance of earlier surgery and the research on hormonal prevention of infertility.

Keywords:
Cryptorchidism, Infertility, Testicular biopsy, Ad spermatogonia
1.
Hadziselimovic F: Cryptorchidism: Management and Implications. New York, Springer-Verlag Berlin Heidelberg, 1983, pp 71-82.
2.
Ritzén EM, Bergh A, Bjerknes R, et al: Nordic consensus on treatment of undescended testes. Acta Paediatr 2007;96:638-643.
3.
Ludwig G, Potempa J: Optimal time for treating cryptorchism. Dtsch Med Wochenschr 1975;100:680-683.
4.
Hadziselimovic F, Herzog B: The importance of both an early orchidopexy and germ cell maturation for fertility. Lancet 2001;358:1156-1157.
5.
Trussell JC, Lee PA: The relationship of cryptorchidism to fertility. Curr Urol Rep 2004;5:142-148.
6.
Li R, Thorup J, Sun C, et al: Immunofluorescent analysis of testicular biopsies with germ cell and Sertoli cell markers shows significant MVH negative germ cell depletion with older age at orchiopexy. J Urol 2014;191:458-464.
7.
Hadziselimovic F, Hocht B, Herzog B, et al: Infertility in cryptorchidism is linked to the stage of germ cell development at orchidopexy. Horm Res 2007;68:46-52.
8.
Kolon TF, Patel RP, Huff DS: Cryptorchidism: diagnosis, treatment, and long-term prognosis. Urol Clin North Am 2004;31:469-480.
9.
Huff DS, Hadziselimovic F, Snyder HM 3rd, Blythe B, Ducket JW: Histologic maldevelopment of unilaterally cryptorchid testes and their descended partners. Eur J Pediatr 1993;152:S11-S14.
10.
Hadziselimovic F, Zivkovic D, Bica DT, et al: The importance of mini-puberty for fertility in cryptorchidism. J Urol 2005;174:1536-1539.
11.
Rubenwolf P, Stein R: [Diagnosis and management of the undescended testis - an update in the light of the current guidelines]. Aktuelle Urol 2013;44:445-451.
12.
Zivkovic D, Varga J, Konstantinidis G, et al: Regional differences in maturation of germ cells of cryptorchid testes: role of environment. Acta Paediatr 2009;98:1339-1343.
13.
Foresta C, Zuccarello D, Garolla A, et al: Role of hormones, genes, and environment in human cryptorchidism. Endocr Rev 2008;29:560-580.
14.
Sultan C, Paris F, Terouanne B, et al: Disorders linked to insufficient androgen action in male children. Hum Reprod Update 2001;7:314-322.
15.
Chung E, Brock GB: Cryptorchidism and its impact on male fertility: a state of art review of current literature. Can Urol Assoc J 2011;5:210-214.
16.
Hadziselimovic F, Hadziselimovic NO, Demougin P, et al: EGR4 is a master gene responsible for fertility in cryptorchidism. Sex Dev 2009;3:253-263.
17.
Hadziselimovic F, Huff D, Duckett J, et al: Treatment of cryptorchidism with low doses of buserelin over a 6-months period. Eur J Pediatr 1987;146:S56-S58.
18.
Rossi V, Sartori A, Bordin G, et al: [Cryptorchidism: medium- and long-term follow-up]. Minerva Pediatr 2013;65:261-269.
19.
Biers SM, Malone PS: A critical appraisal of the evidence for improved fertility indices in undescended testes after gonadotrophin-releasing hormone therapy and orchidopexy. J Pediatr Urol 2010;6:239-246.
20.
Jiang H, Zhu WJ: Cryptorchidism is not a risk factor for antisperm antibody production in post-orchidopexy males with infertility. Urol Int 2013;90:470-474.
21.
Xie BG, Huang YH, Zhu WJ, Jin S: Comparison of the outcome of conventional in vitro fertilization and intracytoplasmic sperm njection in moderate male infertility from ejaculate. Urol Int 2013, Epub ahead of print.
22.
Thorup J, Jensen CL, Langballe O, et al: The challenge of early surgery for cryptorchidism. Scand J Urol Nephrol 2011;45:184-189.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.